HENGRUI PHARMA 01276·

Gross margin 83.61%--84.55%0.94%86.25%1.70%86.21%0.04% Net margin 17.93%--18.75%0.81%22.64%3.90%24.40%1.75% ROE 10.33%--10.63%0.30%13.92%3.29%12.58%1.34% ROA 9.00%--9.77%0.77%12.64%2.87%11.05%1.59% Revenue growth ----7.26%--22.63%15.37%13.02%9.61% Attributable profit growth ----10.14%--47.28%37.14%21.69%25.59% Debt-to-assets 9.34%--6.28%3.06%8.07%1.78%11.55%3.48% Current ratio 8.50--12.253.759.722.538.081.63 Operating cash flow / net profit 0.33--1.791.461.170.621.460.28 Operating cash flow / revenue 5.95%--33.50%27.55%26.52%6.97%35.52%9.00%

Gross margin 86.58%--86.33%0.25% Net margin 28.26%--28.89%0.63% Revenue growth -----1.94%-- Attributable profit growth ----0.34%-- Debt-to-assets ----8.17%-- Current ratio ----11.68-- Operating cash flow / net profit 0.97--0.440.52 Operating cash flow / revenue 27.29%--12.86%14.43%

Revenue 21.28B--22.82B7.26%27.98B22.63%31.63B13.02% Other income and gains 1.37B--1.03B24.61%1.17B13.62%1.47B25.32% Gross profit 17.79B--19.29B8.47%24.14B25.09%27.27B12.97% Selling and distribution expenses 7.35B--7.58B3.12%8.34B10.02%9.11B9.24% Administrative expenses 2.50B--2.64B5.86%2.82B6.45%3.07B9.12% Net finance costs 6.49M--5.91M9.03%5.56M5.86%14.35M158.12% Income tax 153.35M--389.29M153.85%832.70M113.90%990.62M18.97% Operating profit 4.04B--4.75B17.53%7.20B51.65%8.82B22.54% Share of associates and JVs -63.00M---72.70M15.40%-21.58M70.31%-97.14M350.13% Profit before tax 3.97B--4.67B17.60%7.17B53.62%8.71B21.45% Net profit 3.82B--4.28B12.13%6.34B48.14%7.72B21.78% Net profit attributable to owners 3.91B--4.30B10.14%6.34B47.28%7.71B21.69%

Revenue 15.76B--15.46B1.94% Other income and gains 603.80M--1.74B188.09% Cost of sales 2.11B--2.11B0.08% Gross profit 13.65B--13.34B2.23% Selling and distribution expenses 4.39B--4.34B1.10% Administrative expenses 1.41B--1.40B0.71% Net finance costs 11.66M--3.00M74.29% Income tax 596.26M--487.13M18.30% Share of associates and JVs -41.47M---72.12M73.93% Profit before tax 5.05B--4.95B1.95% Net profit 4.45B--4.47B0.24% Net profit attributable to owners 4.45B--4.47B0.34%

Cash and cash equivalents 15.11B--20.75B37.30%24.80B19.55%40.85B64.72% Trade and bills receivables 8.34B--6.13B26.45%6.16B0.40%5.91B4.06% Inventories 2.45B--2.31B5.57%2.42B4.46%2.88B19.08% Total current assets 30.93B--31.29B1.14%35.31B12.87%51.49B45.80% Total assets 42.37B--43.78B3.34%50.14B14.51%69.87B39.36% Total current liabilities 3.64B--2.55B29.83%3.63B42.29%6.37B75.29% Total liabilities 3.96B--2.75B30.48%4.05B47.03%8.07B99.50% Equity attributable to owners 37.82B--40.47B6.99%45.52B12.49%61.27B34.61% Total equity 38.41B--41.03B6.82%46.09B12.32%61.80B34.08%

Cash and cash equivalents ----38.72B-- Trade and bills receivables ----6.25B-- Inventories ----2.99B-- Total current assets ----49.61B-- Total assets ----70.77B-- Total current liabilities ----4.25B-- Total liabilities ----5.78B-- Equity attributable to owners ----64.47B-- Total equity ----64.99B--

Net cash from operating activities 1.27B--7.64B504.12%7.42B2.89%11.24B51.36% Net cash from investing activities 390.29M--1.22B213.18%-1.91B256.42%-2.74B43.33% Net cash from financing activities -318.77M---3.14B886.42%-1.55B50.69%7.78B601.85% Net change in cash 1.34B--5.72B328.01%3.96B30.78%16.28B311.01%

Net cash from operating activities 4.30B--1.99B53.80% Net cash from investing activities -1.08B---1.82B68.21% Net cash from financing activities 8.04B---1.59B119.77% Net change in cash 11.26B---1.43B112.68%